The Cost of HLVd in Cannabis Cultivation

Cannabis leaves from a clean sample compared with plant material testing positive for Hop Latent Viroid (HLVd), illustrating the differences that may be observed in symptomatic infected plants. (Courtesy of Modern Canna Labs)

Hop Latent Viroid (HLVd) has become one of the most consequential plant health challenges facing commercial cannabis cultivation. Its impact extends well beyond visibly sick plants. An infected mother can introduce HLVd into a propagation system, infected plants may occupy production space without reaching their expected potential, and an outbreak can require extensive testing, sanitation, culling, and replacement of plant material.

For commercial cultivators, that makes HLVd more than a plant disease problem. It is a production and business risk that can affect yield, product quality, labor requirements, genetic inventory, and the predictability of future production cycles.

HLVd Can Reduce Both Yield and Product Quality Cost of HLVd in Cannabis

The most obvious economic impact of HLVd is reduced plant performance. Susceptible plants may exhibit reduced vigor, shortened internodes, abnormal growth, smaller flowers, and reduced flower mass. HLVd infection can also impair glandular trichome development and reduce cannabinoid and terpene production. Cost of HLVd in Cannabis

These effects can compound one another commercially. A plant may produce less harvestable flower while the flower it does produce contains lower concentrations of the compounds that contribute to its value. Across a commercial canopy, even moderate reductions in individual plant performance can translate into substantial production losses.

Not every infected plant will show the same response. Symptom expression and severity can vary among cultivars, and infected plants may sometimes appear relatively normal. This makes visual inspection alone an unreliable way to determine whether HLVd is affecting a production population.

HLVd incidence and symptom expression in greenhouse-grown cannabis. Redrawn from published results showing variation in HLVd prevalence among cannabis genotypes and that approximately 70% of HLVd-positive plants in surveyed production beds were asymptomatic. Adapted from Punja, Wang, Lung & Buirs (2023), Symptomology, prevalence, and impact of Hop latent viroid on greenhouse-grown cannabis (Cannabis sativa L.) plants in Canada.

HLVd Increases Testing, Labor, and Management Costs

The cost of HLVd does not end with lost flower. Once infection is detected, facilities may need to expand testing, trace plant movement, identify potentially infected mother stock, remove plants, disinfect propagation and cultivation areas, and determine which genetics can safely remain in production. Those activities require labor that would otherwise be directed toward normal cultivation operations. An outbreak can also disrupt propagation schedules if mothers or clone populations must be removed before replacement material is available.

For facilities operating continuous production cycles, these disruptions can extend beyond the room where HLVd was initially detected. Losing a source mother today can affect the availability of clones needed for production weeks or months later.

HLVd Can Move Through a Propagation System

Vegetative propagation makes HLVd particularly problematic for commercial cannabis. If an infected mother is used as a source for cuttings, the viroid can move directly into the next generation of plants. Contaminated cutting tools and other mechanical contact can further distribute infected sap between plants.

This means a single infected plant can become a much larger operational problem when it enters a propagation system. The risk is especially significant when facilities maintain large mother populations and routinely generate hundreds or thousands of cuttings.

Preventing spread therefore requires more than looking for symptomatic plants. Molecular testing, appropriate sanitation, careful management of incoming genetics, and documented clean stock should be incorporated into facility biosecurity.

The Loss of Genetics Can Be More Expensive Than the Loss of a Crop

For some cultivators, the most valuable plants in the facility are not the plants approaching harvest. They are the mothers holding cultivars that may have taken years to breed, select, acquire, or build into a brand.

When HLVd becomes established in mother stock, the facility faces a difficult problem. Removing infected plants may be necessary to protect production, but eliminating a mother can also mean eliminating the facility's only living copy of that selected genotype.

This is one reason genetic preservation and clean-stock programs are increasingly important in commercial cannabis. Maintaining valuable cultivars outside the active production environment provides another source from which plant material can potentially be recovered or replaced.

An HLVd Outbreak Can Affect Future Production

The economic impact of HLVd should not be measured only by the value of plants that are culled. An outbreak can affect multiple future production cycles.

Replacement mothers require time to establish before they can supply sufficient cuttings. Production schedules may need to change. Rooms may operate below intended plant counts. Cultivars may temporarily disappear from production. Testing and sanitation costs continue while the facility works to establish confidence in its replacement stock.

For businesses operating on tight production schedules, the downstream cost of disruption can become as important as the immediate crop loss.

Preventing HLVd Is Less Expensive Than Managing an Outbreak

No single practice can eliminate the risk of HLVd. Effective prevention depends on multiple layers of plant health management, including testing incoming genetics, maintaining clean source material, sanitation protocols, employee training, routine surveillance, and appropriate biosecurity throughout propagation and production.

Tissue culture can also play an important role in this system. can be used in attempts to recover HLVd-negative material from valuable infected genetics, while tested tissue culture stock can provide a clean baseline from which new mother populations are established. However, clean plants can be reinfected after they return to production, so tissue culture must be paired with continued testing and facility biosecurity.

For commercial cannabis cultivators, the goal is not simply to respond when HLVd appears. It is to build a production system that reduces the probability that a single infected plant becomes a facility-wide problem.